Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis
Open Access
- 1 September 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (9) , 1331-1335
- https://doi.org/10.1128/aac.32.9.1331
Abstract
Cilofungin (LY121019) is an antifungal agent that interferes with beta-glucan synthesis in the cells walls of fungi. The activity of this agent against 256 clinical isolates of yeasts was determined. It was found to be very active in vitro against Candida albicans (MIC for 90% of isolates [MIC90], less than or equal to 0.31 microgram/ml; minimal fungicidal concentration for 90% of isolates [MFC90], less than or equal to 0.31 micrograms/ml) and C. tropicalis (MIC90, less than or equal to 0.31 microgram/ml; MFC90, less than or equal to 0.31 microgram/ml) and moderately active against Torulopsis glabrata (MIC90 and MFC90, less than or equal to 20 micrograms/ml). All C. parapsilosis, Cryptococcus, and Saccharomyces cerevisiae strains were resistant. The activity of cilofungin was affected by medium and inoculum size. Antibiotic medium no. 3 was used as the standard medium. Isolates of C. albicans and C. tropicalis demonstrated a paradoxical effect in Sabouraud dextrose broth and yeast nitrogen base broth in that growth was partially inhibited at MICs equivalent to those in antibiotic medium no. 3, but growth continued, in many instances, throughout all concentrations tested. There was decreased activity of cilofungin with inocula greater than 10(5) CFU/ml. The temperature and duration of incubation did not affect its activity.This publication has 18 references indexed in Scilit:
- Susceptibility of Candida albicans to flucytosine when tested in different formulations of yeast nitrogen base brothDiagnostic Microbiology and Infectious Disease, 1986
- Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicansAntimicrobial Agents and Chemotherapy, 1986
- Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic mediaAntimicrobial Agents and Chemotherapy, 1984
- Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicansFEBS Letters, 1984
- Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicansAntimicrobial Agents and Chemotherapy, 1984
- Synthesis and biological activity of tripeptidyl polyoxins as antifungal agentsAntimicrobial Agents and Chemotherapy, 1983
- Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United StatesAntimicrobial Agents and Chemotherapy, 1982
- Synthesis of the Yeast Cell Wall and its RegulationAnnual Review of Biochemistry, 1982
- Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer MethodsAntimicrobial Agents and Chemotherapy, 1978
- Cell Wall Composition of the Mycelial and Blastospore Forms of Candida albicansJournal of General Microbiology, 1968